As of 2025-10-22, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -0.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 0.28 mil USD. AXDX's TTM EBITDA according to its financial statements is -32.50 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 20.9x | 19.2x |
| Forward P/E multiples | 20.3x - 22.7x | 21.5x |
| Fair Price | (80.04) - (82.56) | (80.21) |
| Upside | -235500.2% - -242929.0% | -236022.6% |
| Date | EV/EBITDA |